Tech Center 1600 • Art Units: 1615
This examiner grants 56% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17608706 | METHODS FOR IMPROVING THE TISSUE SEALING PROPERTIES OF HYDROGELS AND THE USE THEREOF | Final Rejection | The Regents of the University of California |
| 17927168 | METAL-ORGANIC FRAMEWORKS DELIVER SMALL MOLECULES AND BIOMACROMOLECULES FOR CANCER IMMUNOTHERAPY | Non-Final OA | The University of Chicago |
| 17043526 | FIBRIN-SPECIFIC MATERIALS AND METHODS OF USING THEREOF | Non-Final OA | NORTH CAROLINA STATE UNIVERSITY |
| 18651323 | Implantable Drug Eluting System and Method of Use | Final Rejection | P Tech, LLC |
| 18034969 | NON-CATIONIC SOFT POLYPHENOL NANOCAPSULES FOR EFFECTIVE SYSTEMIC DELIVERY OF SMALL INTERFERING RNA (siRNA) FOR CANCER TREATMENT | Non-Final OA | Purdue Research Foundation |
| 18005240 | MEDICAL DEVICES HAVING ANTI-MICROBIAL PROPERTIES AND METHODS FOR MAKING THE SAME | Final Rejection | Hollister Incorporated |
| 17916180 | IMPLANT DEVICES AND METHODS FOR TREATMENT OF CERVICAL CANCER | Final Rejection | Washington University |
| 17997045 | A NUTRITIONAL PRODUCT CONTAINING A BUFFER COMPOSITION AND AN AMINO ACID AND METHODS OF USING SUCH A NUTRITIONAL PRODUCT | Final Rejection | SOCIETE DES PRODUITS NESTLE S.A. |
| 18458986 | CELLULOSE ACETATE PARTICLES | Final Rejection | FUJIFILM Business Innovation Corp. |
| 17539648 | COMPOSITE PARTICLES AND METHOD OF PRODUCING THE SAME, PERSONAL CARE PRODUCT, PERSONAL CARE PARTICLES AND METHOD OF PRODUCING THE SAME, PERSONAL CARE ARTICLE, AND PERSONAL CARE COMPOSITION | Non-Final OA | TOPPAN INC. |
| 18027655 | Inhaled PDE-V Inhibitor Drugs | Final Rejection | Pinata Holdings Inc. |
| 18667729 | MEANS AND METHODS FOR WOUND HEALING | Non-Final OA | KATHOLIEKE UNIVERSITEIT LEUVEN, K.U.LEUVEN R&D |
| 18645334 | COMPOSITIONS AND METHODS FOR ENHANCING THE EFFICACY OF CONTRACEPTIVE MICROBICIDES | Final Rejection | EVOFEM, INC. |
| 18641362 | Magnetic Fungicide | Non-Final OA | MAGFU OÜ |
| 18689987 | COSMETIC METHOD FOR TREATING HAIR WITH OZONE | Non-Final OA | Federico Montanari |
| 18683975 | MODIFIED COLLOIDAL PARTICLES FOR USE IN THE TREATMENT OF HAEMOPHILIA A | Non-Final OA | Cantab Biopharmaceuticals Patents Limited |
| 18394246 | Protease Inhibitor-Containing Compositions, Compositions Comprising Same, and Methods for Producing and Using Same | Non-Final OA | Oramed Ltd. |
| 18254983 | ORAL THERAPEUTIC DELIVERY | Non-Final OA | ROYAL MELBOURNE INSTITUTE OF TECHNOLOGY |
| 18261213 | PHARMACEUTICAL COMPOSITIONS COMPRISING ACALABRUTINIB | Final Rejection | NATCO PHARMA LIMITED |
| 17440575 | MAGNESIUM HYDROXIDE FOR USE AS A CONTACT FUNGICIDE IN AGRICULTURE | Non-Final OA | Timab Magnesium |
| 18176890 | BIO-INSPIRED TISSUE-ADHESIVE HYDROGEL PATCH FOR PREVENTING OR TREATING CARTILAGE OR BONE DISEASE | Final Rejection | CELLARTGEN INC. |
| 17581999 | FORMULATION AND DEVICE FOR COSMETIC TREATMENT OF ONYCHOMYCOSIS | Final Rejection | Scholl's Wellness Company LLC |
| 18256304 | METHOD OF TREATING HEREDITARY HEMORRHAGIC TELANGIECTASIA USING PAZOPANIB | Final Rejection | HHT Foundation International, Inc. |
| 18203863 | ORAL SOFT CAPSULE THAT ENCAPSULATES A NALBUPHINE FORMULATION | Final Rejection | PHYTOHEALTH CORPORATION |
| 17691572 | N-PALMITOYL-ETHANOLAMIDE FOR USE IN THE PREVENTION OF COLORECTAL CARCINOMA | Non-Final OA | EPITECH GROUP S.P.A. |
| 18044407 | NANOPARTICLES FOR TREATING OR PREVENTING A CARDIOMYOPATHY AND ANTHRACYCLINE-CYTOTOXICITY, AND THEIR ADMINISTRATION AS AN AEROSOL | Non-Final OA | CHROMALYS |
| 17890809 | PROTECTING TISSUE AND MITIGATING INJURY FROM RADIATION-INDUCED IONIZING EVENTS | Final Rejection | Humanetics Corporation |
| 17754657 | ANTIMICROBIAL COMPOSITION FOR ANIMAL FEED | Final Rejection | Taminco BV |
| 17286352 | LIPID COMPOSITION CONTAINING MICRONUTRIENTS FOR THE PREVENTION AND/OR TREATMENT OF METABOLIC DISEASES | Final Rejection | TEAM FOODS COLOMBIA S.A. |
| 17280381 | CALCIUM COMPOSITION | Non-Final OA | PerformaNat GmbH |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy